v3.25.4
Collaborations and Other Arrangements - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue $ 65,179 $ 45,043 $ 34,124
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Olanzapine Portfolio      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue recognized     1,400
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Baqsimi      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue recognized     579
Milestone payment received 450    
Jardiance      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue 3,432 3,341 $ 2,745
Jardiance | One Time Payment Received      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue 370 $ 300  
Jardiance | Milestone Payments, Sales-based      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue 200    
Potential achievements 910    
Ebglyss | Milestone Payments, Sales-based      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Potential achievements 1,200    
Ebglyss | Milestone Payments, Sales-based | Roche      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Potential achievements $ 975